Nexvet Eyes IPO Pricing Of $13-$16 a Share
January 26, 2015 at 07:26 AM EST
Nexvet Biopharma on Monday set terms of its planned initial public offering, saying in a filing with the U.S. Securities and Exchange Commission it expects 4 million ordinary shares to be priced between $13 to $16 a share.
